PEP

Summary

Initiate a measured long position in PEP at current levels (~$140.47), scaling in half now and half on a confirmed break above the $143.22–$143.50 resistance zone. Position size should be moderate given elevated IV (30.2%) and legitimate leverage/North American demand concerns — this is a value/income position with defined risk, not an aggressive momentum bet. Place a stop below the $137.73 swing low (~$136.50–$137.00, roughly 2.5–3% below entry, consistent with ATR of 2.80 and 0.36 beta). First target $143.22–$143.50 (Bollinger upper band/swing high), second target $147.15 (200 SMA); a sustained break above the 200 SMA opens the path toward the $155 consensus target. Time horizon is multi-month, with the 4.27% dividend yield providing income while the H2 2026 margin-expansion catalyst develops. Our analysis assigns a modest but genuine edge to the long side, supporting an Overweight stance rather than a neutral hold.

The case

The decisive fundamental fact is that PEP's 2025 net income decline was driven by a $1.993B non-cash impairment charge, not operational deterioration: normalized EBITDA rose from $16.71B to $17.54B, normalized income from $9.60B to $9.85B, and revenue from $91.85B to $93.93B. The value-trap thesis materially weakens once this impairment — the single most important finding — is accounted for. The bull case is more comprehensive: a higher-low structure since the July 23 bottom, VWMA volume confirmation, a 15.65x forward P/E versus KO's premium, a 4% dividend hike signaling management confidence, and foods-segment volume recovery. The technical setup is short-term bullish (price above 10 EMA and 50 SMA, MACD bullish crossover, RSI >50) within a longer-term downtrend (declining 200 SMA at 147.15, price 4.5% below it).

We weight the valid concerns — $40B net debt, negative tangible book value, dividend consuming nearly all FCF, weak North American demand, and promotional-spending margin pressure — but judge them largely priced in at a 52-week-low valuation with a 4.27% yield and 0.36 beta. The bull case also overreaches slightly (dividend hikes are not always pure confidence signals; leverage is dismissed too casually; value-pack growth does carry a consumer-strain signal), which is why we temper conviction rather than go aggressive.

Our analysis reinforces a directional commitment: when a verifiable fundamental catalyst (the impairment-driven earnings normalization) is present, a neutral hold would miss the directional swing. We therefore commit to Overweight rather than hedging into a neutral stance. The edge is genuine but modest, reflecting the tension between improving normalized fundamentals and an intact longer-term downtrend, with the near-term window capturing the short-term bullish momentum toward the $143.22–$143.50 resistance zone.

What would weaken it

• $40B net debt and negative tangible book value
• Dividend consuming nearly all FCF
• Weak North American demand and promotional margin pressure